ARCHIVES

Study Suggests Biomarker For Resistance to Tamoxifen

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

NCI funds biorepository for prostate cancer SPOREs.

November 11, 2005

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006